Author:
Lee Ji-Ho,Lee Won-Yeon,Yong Suk Joong,Kim Woo Jin,Sin Sooim,Lee Chang Youl,Kim Youlim,Jung Ji Ye,Kim Sang-Ha,Oh Yeon-Mok,Lee Hyun,Choi Hayoung,Sim Yun Su,Yoo Kwang Ha,Lee Seung Jun,Kim Tae-Hyung,Yang Bumhee,Jeong Ina,Um Soo-Jung,Kim Deog Kyeom,Lee Ji-Hyun,Kwon Byoung Soo,Cho Young-Jae,Lee Chang-Hoon,Rhee Chin Kook,Lee Sang Haak,Na Ju-Ok,Jang An-Soo,Kim Changhwan,Kim Hyun Kuk,Park Hye Yun,Lee Jae Seung,Lee Sei Won,Ra Seung Won,Kang Sung-Yoon,Kim Yee Hyung,Park Yong Bum,Park So-Young,Kim Junghyun,Yoon Young-Soon,Jeong Yun Jeong,Lee Jung-Kyu,Kim Ki Uk,Lee Hyun-Kyung,Kim Eun Kyung,Lee Se Hee,Choi Jae Sung,Kang Hyung Koo,Kwon Yong-Soo,Lee Jae Ha,
Abstract
Abstract
Background
With the emergence of bronchiectasis as a common respiratory disease, epidemiological data have accumulated. However, the prevalence and impact of psychological comorbidities were not sufficiently evaluated. The present study examined the prevalence of depression and its associated factors in patients with bronchiectasis.
Methods
This study involved a multicenter cohort of bronchiectasis patients recruited from 33 pulmonary specialist hospitals. The baseline characteristics and bronchiectasis-related factors at enrollment were analyzed. Depressive symptoms were assessed using the Patient Health Questionnaire (PHQ-9).
Results
Of the 810 patients enrolled in the study, 168 (20.7%) patients had relevant depression (PHQ-9 score ≥ 10), and only 20 (11.9%) patients had a diagnosis of depression. Significant differences were noted in the depressive symptoms with disease severity, which was assessed using the Bronchiectasis Severity Index and E-FACED (all p < 0.001). Depressive symptoms inversely correlated with quality-of-life (r = − 0.704, p < 0.001) and positively correlated with fatigue severity score (r = 0.712, p < 0.001). Multivariate analysis showed that depression was significantly associated with the modified Medical Research Council dyspnea scale ≥ 2 (OR 2.960, 95% CI 1.907–4.588, p = < 0.001) and high number of exacerbations (≥ 3) in the previous year (OR 1.596, 95% CI 1.012–2.482, p = 0.041).
Conclusions
Depression is common, but its association with bronchiectasis was underrecognized. It negatively affected quality-of-life and presented with fatigue symptoms. Among the bronchiectasis-related factors, dyspnea and exacerbation were closely associated with depression. Therefore, active screening for depression is necessary to optimize the treatment of bronchiectasis.
Trial registration
The study was registered at Clinical Research Information Service (CRiS), Republic of Korea (KCT0003088). The date of registration was June 19th, 2018.
Publisher
Springer Science and Business Media LLC
Subject
Pulmonary and Respiratory Medicine